Haemonetics | HAE - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Baxter International USD 735M 7M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Cerus USD 19.33M 1.55M 2024-12
Cooper Companies USD 676.2M 303.1M 2026-03
Fresenius EUR 760M 17M 2026-06
Fresenius Medical Care EUR 736.01M 12.99M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
Haemonetics USD 118.94M 1.99M 2026-06
ICU Medical USD 151.92M 2.64M 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
Medtronic 2.96B 9M 2025-12
Merit Medical Systems USD 129.23M 18.76M 2026-06
Neogen USD 99.8M 1.3M 2026-03
OraSure Technologies USD 13.21M 3.29M 2025-12
Plus Therapeutics USD 4.26M 779K 2026-03
Quidel USD 189.7M 9.6M 2026-06
ResMed USD 290.65M 10.86M 2026-06
STAAR Surgical USD 38.64M 299K 2026-03
Steris USD 369.7M 17.9M 2026-06
Stryker USD 2.12B 32M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
Terumo JPY 109.7B 5.11B 2026-06
Thermo Fisher Scientific USD 1.91B 111M 2026-06
US Physical Therapy USD 19M 731K 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06